🇺🇸 FDA
Patent

US 11413337

Peptide conjugated particles for the treatment of inflammation

granted A61KA61K2039/55555A61K2039/577

Quick answer

US patent 11413337 (Peptide conjugated particles for the treatment of inflammation) held by Northwestern University expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/55555, A61K2039/577, A61K2039/6093, A61K39/0005